Alphatec Holdings, Inc. (ATEC) stock
ATECNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.07+0.01 (+0.14%)
Close on Nov 13, 2026Market cap $1.10BP/E –Yield –
Alphatec r&d expenses
Research and development expenses are spending on new products and technology.
Alphatec's R&D Expenses for the twelve months ending Sep 30, 2026 was $76.02M, down 1.0% year over year. For fiscal 2025 it was $76.27M, down 5.5% from the year before. Over ten years it grew 15.8% a year on average. The highest annual figure on record is $80.72M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $76.27M | -5.5% |
| FY2024 | Dec 31, 2024 | $80.72M | +15.1% |
| FY2023 | Dec 31, 2023 | $70.12M | +59.2% |
| FY2022 | Dec 31, 2022 | $44.03M | +37.5% |
| FY2021 | Dec 31, 2021 | $32.02M | +70.8% |
| FY2020 | Dec 31, 2020 | $18.75M | +35.4% |
| FY2019 | Dec 31, 2019 | $13.85M | +40.6% |
| FY2018 | Dec 31, 2018 | $9.85M | +100.3% |
| FY2017 | Dec 31, 2017 | $4.92M | -46.8% |
| FY2016 | Dec 31, 2016 | $9.25M | -47.5% |
| FY2015 | Dec 31, 2015 | $17.62M | +6.2% |
| FY2014 | Dec 31, 2014 | $16.59M | +16.9% |
| FY2013 | Dec 31, 2013 | $14.19M | -4.7% |
| FY2012 | Dec 31, 2012 | $14.89M | -11.9% |
| FY2011 | Dec 31, 2011 | $16.89M | +2.8% |
| FY2010 | Dec 31, 2010 | $16.43M | +21.8% |
| FY2009 | Dec 31, 2009 | $13.49M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.00M | -3.6% |
| Q2 FY2026 | Jun 30, 2026 | $18.17M | -0.6% |
| Q1 FY2026 | Mar 31, 2026 | $17.56M | +5.9% |
| Q4 FY2025 | Dec 31, 2025 | $22.28M | -4.1% |
| Q3 FY2025 | Sep 30, 2025 | $18.68M | -8.2% |
| Q2 FY2025 | Jun 30, 2025 | $18.28M | -4.3% |
| Q1 FY2025 | Mar 31, 2025 | $16.58M | -7.9% |
| Q4 FY2024 | Dec 31, 2024 | $23.24M | +4.3% |
| Q3 FY2024 | Sep 30, 2024 | $20.36M | +1.8% |
| Q2 FY2024 | Jun 30, 2024 | $19.11M | +31.1% |
| Q1 FY2024 | Mar 31, 2024 | $18.01M | +35.8% |
| Q4 FY2023 | Dec 31, 2023 | $22.28M | +92.0% |
| Q3 FY2023 | Sep 30, 2023 | $20.00M | +65.1% |
| Q2 FY2023 | Jun 30, 2023 | $14.57M | +37.5% |
| Q1 FY2023 | Mar 31, 2023 | $13.26M | +36.4% |
| Q4 FY2022 | Dec 31, 2022 | $11.60M | +29.2% |
| Q3 FY2022 | Sep 30, 2022 | $12.11M | +29.0% |
| Q2 FY2022 | Jun 30, 2022 | $10.60M | +35.2% |
| Q1 FY2022 | Mar 31, 2022 | $9.72M | +67.6% |
| Q4 FY2021 | Dec 31, 2021 | $8.98M | +67.8% |
| Q3 FY2021 | Sep 30, 2021 | $9.39M | +88.4% |
| Q2 FY2021 | Jun 30, 2021 | $7.84M | +85.0% |
| Q1 FY2021 | Mar 31, 2021 | $5.80M | +39.1% |
| Q4 FY2020 | Dec 31, 2020 | $5.36M | +55.8% |
| Q3 FY2020 | Sep 30, 2020 | $4.98M | +31.2% |
| Q2 FY2020 | Jun 30, 2020 | $4.24M | +30.7% |
| Q1 FY2020 | Mar 31, 2020 | $4.17M | +23.7% |
| Q4 FY2019 | Dec 31, 2019 | $3.44M | +18.4% |
| Q3 FY2019 | Sep 30, 2019 | $3.80M | +20.4% |
| Q2 FY2019 | Jun 30, 2019 | $3.24M | +61.3% |
| Q1 FY2019 | Mar 31, 2019 | $3.37M | +88.8% |
| Q4 FY2018 | Dec 31, 2018 | $2.90M | +101.9% |
| Q3 FY2018 | Sep 30, 2018 | $3.16M | +202.4% |
| Q2 FY2018 | Jun 30, 2018 | $2.01M | +102.9% |
| Q1 FY2018 | Mar 31, 2018 | $1.79M | +23.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.44M | -41.3% |
| Q3 FY2017 | Sep 30, 2017 | $1.04M | – |
| Q2 FY2017 | Jun 30, 2017 | $990.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $1.45M | – |
| Q4 FY2016 | Dec 31, 2016 | $2.45M | – |
See a number that looks wrong?